The alarming rise in overdose deaths involving stimulants such as cocaine, methamphetamines and amphetamines presents urgent public health concern. Between 2017 and 2025, state health agencies have documented a sharp increase in fatalities linked to these substances. Despite the growing crisis, there are currently no FDA-approved medications for treating psychostimulant addiction—underscoring the need to explore effective and evidence-based alternatives.
This presentation examines critical trends and statistics surrounding stimulant misuse, along with the short- and long-term neurological effects of these drugs on the brain and body. Participants will explore emerging research on potential pharmacological treatments and the proven effective-ness of cognitive behavioral therapy (CBT) in addressing stimulant use disorders.
